Anbio Biotechnology (NNNN) Other Accumulated Expenses (2023 - 2025)

Anbio Biotechnology has reported Other Accumulated Expenses for 3 years, with the latest figure at $87836.0 in Q4 2025.

• For the quarter ending Q4 2025, Other Accumulated Expenses fell 16.33% year-over-year to $87836.0; the trailing twelve-month figure through Dec 2025 stood at $87836.0 (down 16.33% YoY), and the FY2025 full-year result was $87836.0, down 16.33% from the prior year.
• Other Accumulated Expenses for Q4 2025 stood at $87836.0, down from $104979.0 in the prior quarter.
• The five-year high for Other Accumulated Expenses was $165909.0 in Q4 2023, with the low at $87836.0 in Q4 2025.
• Average Other Accumulated Expenses over 3 years is $119574.7, with a median of $104979.0 recorded in 2024.
• Year-over-year, Other Accumulated Expenses slumped 36.72% in 2024 and dropped 16.33% in 2025.
• Tracing NNNN's Other Accumulated Expenses over 3 years: stood at $165909.0 in 2023, then tumbled by 36.72% to $104979.0 in 2024, then decreased by 16.33% to $87836.0 in 2025.
• The last three Other Accumulated Expenses figures came in at $87836.0 (Q4 2025), $104979.0 (Q4 2024), and $165909.0 (Q4 2023), per Business Quant data.

Peer Comparison